This inventor holds 3 USPTO granted patents. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2006 - 2009)
- Somerville, MA (US) (2011)
Company Filing History:
Years Active: 2006-2011
Title: The Innovations of Michael S. Kay
Introduction
Michael S. Kay is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the study of proteins related to HIV. With a total of 3 patents to his name, his work has garnered attention for its innovative approaches to understanding viral structures.
Latest Patents
Among his latest patents, Michael S. Kay has developed the Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41. This protein is separated by linkers, such as amino acid residue linkers. Additionally, he has patented the Six-Helix protein, which includes all three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, also separated by linkers. These innovations are crucial for advancing the understanding of HIV and potential therapeutic approaches.
Career Highlights
Michael S. Kay is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work is characterized by a focus on the structural biology of proteins, particularly those involved in viral infections. His contributions have been instrumental in the ongoing fight against HIV.
Collaborations
Michael S. Kay has collaborated with notable colleagues, including Michael J. Root and David C. Chan. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in the field.
Conclusion
Michael S. Kay's innovative work in protein research, particularly related to HIV, showcases his dedication to advancing biomedical science. His patents reflect a commitment to understanding complex viral structures and developing potential therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
